Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation
Joana Torres, María Chaparro, Mette Julsgaard, et al.
Journal of Crohn s and Colitis (2022) Vol. 17, Iss. 1, pp. 1-27
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
Hannah Gordon, Silvia Minozzi, Uri Kopylov, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 71
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases
Claudia Herrera‐deGuise, X Serra-Ruiz, Ernesto Lastiri, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 47
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis
Antonietta Gerarda Gravina, Raffaele Pellegrino, Marina Cipullo, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 1, pp. 17-33
Open Access | Times Cited: 31
Acute severe ulcerative colitis management: unanswered questions and latest insights
Pauline Rivière, C Li Wai Suen, María Chaparro, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 251-262
Open Access | Times Cited: 23
Understanding the therapeutic toolkit for inflammatory bowel disease
Sophie Vieujean, Vipul Jairath, Laurent Peyrin‐Biroulet, et al.
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 5
Inflammatory bowel disease in pregnancy and breastfeeding
Max N. Brondfield, Uma Mahadevan
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 504-523
Closed Access | Times Cited: 40
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
Piotr Eder, Michał Łodyga, Magdalena Gawron-Kiszka, et al.
Gastroenterology Review (2023) Vol. 18, Iss. 1, pp. 1-42
Open Access | Times Cited: 30
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry
Rishika Chugh, Millie D. Long, Yue Jiang, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 3, pp. 468-476
Closed Access | Times Cited: 26
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis
Sarah Bencardino, Ferdinando D’Amico, Ilaria Faggiani, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5014-5014
Open Access | Times Cited: 25
Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation
Ole Haagen Nielsen, John Gubatan, Kaija‐Leena Kolho, et al.
The Lancet (2024) Vol. 403, Iss. 10433, pp. 1291-1303
Closed Access | Times Cited: 15
Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry
Sara Lewin, Millie D. Long, Russell D. Cohen, et al.
Inflammatory Bowel Diseases (2025)
Closed Access | Times Cited: 1
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
Shiyi Wang, Xiaojian Wang, Jing Ding, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Risk Factors for Contraceptive Failure and Unintended Pregnancy Among Women With Inflammatory Bowel Disease
Erica J. Brenner, Xian Zhang, Uma Mahadevan, et al.
Inflammatory Bowel Diseases (2025)
Closed Access | Times Cited: 1
ECCO Topical Review on Biological Treatment Cycles in Crohn’s Disease
Nurulamin M Noor, Paula Sousa, Dominik Bettenworth, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 7, pp. 1031-1045
Open Access | Times Cited: 18
Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis
Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 695-697
Open Access | Times Cited: 18
Assessing socio-ecological factors on caesarean section and vaginal delivery: an extended perspective among women of South-Punjab, Pakistan
Muhammad Muneeb Hassan, Muhammad Ameeq, Laraib Fatima, et al.
Journal of Psychosomatic Obstetrics & Gynecology (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 18
Vaccines in Children Exposed to Biological AgentsIn Uteroand/or During Breastfeeding: Are They Effective and Safe?
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 995-1009
Closed Access | Times Cited: 17
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy
Mette Julsgaard, Jantien W. Wieringa, Simon Mark Dahl Baunwall, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 8
Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies
Matti Waterman, Yuri Gorelik, Itai Ghersin, et al.
Endoscopy (2024) Vol. 56, Iss. 09, pp. 706-709
Closed Access | Times Cited: 7
Intestinal ultrasound: Is it time to join our IBD units? How do we do it?
T Castro Aguilar-Tablada, A. García
Revista Andaluza de Patología Digestiva (2024) Vol. 47, Iss. 2, pp. 72-79
Open Access | Times Cited: 7
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease
Antoine Meyer, Sara Miranda, Jérôme Drouin, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 1, pp. 144-153.e22
Closed Access | Times Cited: 6
New drugs for the treatment of IBD during conception, pregnancy, and lactation
Daniela Pugliese, Giuseppe Privitera, Javier P. Gisbert, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 2, pp. 235-241
Closed Access | Times Cited: 15
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care
Ahmed B. Bayoumy, Chris J. Mulder, Azhar Ansari, et al.
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 36-47
Open Access | Times Cited: 6
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
Hsu‐Heng Yen, Jia‐Feng Wu, Horng‐Yuan Wang, et al.
Intestinal Research (2024) Vol. 22, Iss. 3, pp. 213-249
Open Access | Times Cited: 6
Modern practical management of acute severe colitis
Alaa Abdelmeguid, Emma Whitehead, Shaji Sebastian
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 78-92
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top